FindTrial
Sign In

Comparison of radiofrequency ablation and surgical resection in patients with early recurrent liver cancer

Comparison of the efficacy and safety of radiofrequency ablation and surgical resection in patients with early recurrent liver cancer after surgical resection

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047398
Enrollment
Unknown
Registered
2021-06-16
Start date
2021-06-16
Completion date
Unknown
Last updated
2022-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

recurrent hepatocellular carcinoma

Interventions

surgical resection group:surgical resection
radiofrequency ablation group:radiofrequency ablation

Sponsors

Shandong Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Surgical resection is the primary treatment after diagnosis of hepatocellular carcinoma, and SR or RFA treatment is given after recurrence; 2. Age older than 18 years; 3. The number of patients with tumors <= 3, and the longest tumor diameter <= 5cm; 4. No evidence of vascular or bile duct invasion; 5. Child-Pugh class A or B; 6. Recurrence occurring within two years after surgical resection.

Exclusion criteria

Exclusion criteria: 1. Plate counts < 50000/L; 2. Presence of extrahepatic metastasis; 3. Serious cardiopulmonary insufficiency.

Design outcomes

Primary

MeasureTime frame
Overall survival;Progression-free survival;—

Secondary

MeasureTime frame
Postoperative complication;Hospital stay;—

Countries

China

Contacts

Public ContactZhu Qiang

Shandong Provincial Hospital

zhuqiang@sdu.edu.cn+86 15168887780

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026